Tech Company Financing Transactions

KSQ Therapeutics Funding Round

KSQ Therapeutics secured a $80 million Series C funding round on 9/29/2018. Investors included Alexandria Venture Investments, Arch Venture Partners and Baillie Gifford.

Transaction Overview

Company Name
Announced On
9/29/2018
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series C
Proceeds Purpose
With the financing, KSQ will advance its first drug program into the clinic within the next 18 months and up to three additional oncology drug programs into IND-enabling studies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
610 Main St. North 4th Floor
Cambridge, MA 02139
USA
Email Address
Overview
KSQ Therapeutics is pioneering High-Confidence Drug Development: a fundamentally new approach to R&D where the majority of the de-risking work is done prior to the generation of therapeutic drug candidates.
Profile
KSQ Therapeutics LinkedIn Company Profile
Social Media
KSQ Therapeutics Company Twitter Account
Company News
KSQ Therapeutics News
Facebook
KSQ Therapeutics on Facebook
YouTube
KSQ Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Meeker
  David Meeker LinkedIn Profile  David Meeker Twitter Account  David Meeker News  David Meeker on Facebook
Chief Financial Officer
Douglas Pagán
  Douglas Pagán LinkedIn Profile  Douglas Pagán Twitter Account  Douglas Pagán News  Douglas Pagán on Facebook
Chief Financial Officer
John Trzupek
  John Trzupek LinkedIn Profile  John Trzupek Twitter Account  John Trzupek News  John Trzupek on Facebook
Chief Scientific Officer
Frank Stegmeier
  Frank Stegmeier LinkedIn Profile  Frank Stegmeier Twitter Account  Frank Stegmeier News  Frank Stegmeier on Facebook
Vice President
Caroline Dugopolski
  Caroline Dugopolski LinkedIn Profile  Caroline Dugopolski Twitter Account  Caroline Dugopolski News  Caroline Dugopolski on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/29/2018: NetraDyne venture capital transaction
Next: 9/29/2018: SnapMD venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary